3.236.145.153
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Smith-Lemli-Opitz Syndrome

Cholic acid intervention demonstrates safe and well-tolerated rise in cholesterol for SLOS

Patients with Smith-Lemli-Opitz syndrome (SLOS) with low plasma cholesterol levels treated with cholic acid supplementation experienced a significant increase in plasma cholesterol levels after 2 months, according to a pilot study. The standard therapy for SLOS often involves dietary cholesterol supplementation. However, due to impaired bile acid synthesis, the absorption...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
Videos
24 Aug, 2023

Ellen Elias, MD: My name is Ellen Roy Elias. I...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-